⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17106385 | 1.00 | — | — | |
| SCHEMBL15785692 | 0.78 | FFAR3 (0.32) | — | |
| SCHEMBL17106322 | 0.78 | FFAR3 (0.32) | — | |
| SCHEMBL17131051 | 0.78 | FFAR3 (0.48) | — | |
| SCHEMBL15768495 | 0.77 | MEN1 (0.35) | — | |
| SCHEMBL17106402 | 0.77 | MEN1 (0.35) | — | |
| SCHEMBL11338238 | 0.76 | FFAR3 (0.31) | — | |
| Formaldehyde SCHEMBL17106253 | 0.74 | FFAR3 (0.30) | — | |
| SCHEMBL17106415 | 0.73 | CYP19A1 (0.33) | — | |
| SCHEMBL17130777 | 0.73 | CYP19A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| WO-2015148743-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | disclosed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | disclosed |